DIPG-29. A CONNECT CONSORTIUM PRECLINICAL STUDY IDENTIFIES MEK INHIBITION AND RADIATION AS POTENTIAL COMBINATION PARTNERS FOR THE ALK2 INHIBITOR TP-0184 IN ACVR1-MUTANT DMG

Somatic mutations in ACVR1, which encodes the serine/threonine kinase ALK2, are found in 20-25% of DMG-H3K27 patients. Treatment of ACVR1-mutant orthotopic xenografts with multiple chemotypes of ALK2 inhibitors (ALK2i) results in extended survival in vivo but, as single agents, these inhibitors are...

Descripción completa

Detalles Bibliográficos
Autores principales: Rogers, Rebecca, Tsoli, Maria, Kumar, Shiva Senthil, Potente, Elisabet Fernandez, Biery, Matt, Grabovska, Yura, Mackay, Alan, Carvalho, Diana, Pereria, Rita, Burford, Anna, Sejdiu, Drenusha, Ruddle, Ruth, Gabel, Florian, Raynaud, Florence, Yadavilli, Sridevi, Mizoguchi, Sean, Subramaniam, Bavani, Kilburn, Lindsey, Hwang, Eugene, Nazarian, Javad, Vitanza, Nicholas, Ziegler, David, Drissi, Rachid, Jones, Chris
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Final Category: Diffuse Intrinsic Pontine Glioma/Diffuse Midline Gliomas - DPIG
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10259951/
http://dx.doi.org/10.1093/neuonc/noad073.076

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10259951/
http://dx.doi.org/10.1093/neuonc/noad073.076

Ejemplares similares